Landscapes / Companies
Alpha Biopharma (Jiangsu) Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
1 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Zorifertinibnot checked |
Tyrosine kinase inhibitor |
Phase 1 | 23 Apr 2028Phase 1 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | 23 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment | ||||
| Open drug page | |||||
About
- No active trial
- AZD3759
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021